Concepedia

Amy Loercher

AL

Statistics

Publications

11

Citations

838

H-Index

10

Active since

1997

Affiliations

GlaxoSmithKline (United States)(Current)

GlaxoSmithKline (United Kingdom)

University College London

The University of Texas MD Anderson Cancer Center

Centre National de la Recherche Scientifique

Amy Loercher is an author at GlaxoSmithKline (United States) specializing in pharmacology, medicine, and oncology.

Publications per year

1997–2020

11

Publications

11

MITF links differentiation with cell cycle arrest in melanocytes by transcriptional activation of INK4A

Amy Loercher, Elizabeth M.H. Tank, Rachel B. Delston et al. · The Journal of Cell Biology · 2004 · 258 citations · Full text

Life Sciences, Cell Biology, Molecular Biology +17

Identification of an IL-10-Producing HLA-DR-Negative Monocyte Subset in the Malignant Ascites of Patients with Ovarian Carcinoma That Inhibits Cytokine Protein Expression and Proliferation of Autologous T Cells

Amy Loercher, M A Nash, John J. Kavanagh et al. · The Journal of Immunology · 1999 · 176 citations · Full text

Life Sciences, Immunology, Oncology +17

Nuclear Factor-κB is an Important Modulator of the Altered Gene Expression Profile and Malignant Phenotype in Squamous Cell Carcinoma

Amy Loercher, Justin L. Ricker, April Howard et al. · Cancer Research · 2004 · 167 citations · Full text

Medicine, Cancer Biology, Oncology +12

Clinicogenomic factors of biotherapy immunogenicity in autoimmune disease: A prospective multicohort study of the ABIRISK consortium

Signe Hässler, Delphine Bachelet, Julianne Duhazé et al. · PLoS Medicine · 2020 · 55 citations · Full text

Life Sciences, Immunology, Pharmacology +17

Growth inhibitory effects of aromatic fatty acids on ovarian tumor cell lines.

Bohuslav Melichar, Gabriella Ferrandina, Claire F. Verschraegen et al. · PubMed · 1998 · 42 citations

Medicine, Oncology, Pharmacology +13

1–5 of 11